Precision Over Aggression: Evolving Strategies for Skull Base Tumor Treatment

For benign skull base tumors, the goal is increasingly durable tumor control with functional preservation over maximal resection.

By
October 13, 2026
6 min

Keck Medicine of USC

Overview

Management of benign skull base tumors is shifting from maximal resection toward durable tumor control with preservation of cranial nerve and other neurologic function. The article describes multidisciplinary, individualized planning and a function-preserving approach to vestibular schwannoma surgery, with stereotactic radiosurgery available for residual or recurrent tumor. Investigational optical coherence tomography may improve intraoperative visualization, but its clinical role remains under development.

Background

Skull base tumors arise near structures essential to hearing, facial movement, swallowing, vision, and balance. The article reports that aggressive resection has been associated with cranial nerve deficits, including facial nerve palsy, hearing loss, dysphagia, and diplopia. Vestibular schwannomas are generally benign and slow-growing, but their removal can affect the facial nerve and auditory function. Related guidance for skull base meningioma similarly describes maximum safe resection with low morbidity and preservation of neurologic function, with radiotherapy or radiosurgery considered when complete resection is not feasible.

Data Highlights

Evidence or technology	Reported finding
2016 multicenter vestibular schwannoma study, co-authored by Oghalai	Better immediate cranial nerve VII function was associated with leaving a greater percentage of tumor behind.
2026 long-term results from the same study	Extent of resection was not independently associated with facial nerve outcomes; larger residual tumors carried a greater risk of regrowth.
2026 CNS hearing-preservation guideline update, as summarized in web research context	Serviceable hearing preservation was 78%, 59%, and 47% at 2, 5, and 10 years with observation; 71%, 59%, and 38% after stereotactic radiosurgery; and 48%, 40%, and 32% after microsurgery.
2026 CNS radiosurgery/radiation guideline update, as summarized in web research context	For adults with sporadic intracanalicular or less than 2 cm vestibular schwannoma, stereotactic radiosurgery was not recommended as superior to observation for hearing preservation; cochlear dose constraint should be considered, and single-fraction radiosurgery was recommended over hypofractionated radiosurgery to reduce cranial nerve dysfunction.
2026 CyberKnife systematic review/meta-analysis, as summarized in web research context	Included series reported 96% local control and 73% hearing preservation, with low rates of major cranial neuropathy.

Key Findings

The article describes a shift in benign skull base tumor management from maximal resection toward durable control while minimizing functional morbidity.
At Keck Medicine, cases are reviewed by a multidisciplinary team that includes neurotology, neurosurgery, radiation oncology, neurology, neuroradiology, and neuropathology; patients make the final treatment decision after a recommendation is discussed.
For vestibular schwannoma, less aggressive dissection may help preserve immediate facial nerve function, while stereotactic radiation can be used for residual or recurrent tumor when necessary.
Long-term results published in 2026 from the cited multicenter study found no independent association between extent of resection and facial nerve outcomes, while larger residual tumors were associated with greater regrowth risk.
The article reports use of a frameless Gamma Knife system at Keck Medicine; investigational intraoperative optical coherence tomography is being developed to visualize inner-ear structures and potentially identify nerves and vessels beneath a tumor surface.
The 2026 CNS guideline summary reports that fewer than half of patients maintained serviceable hearing at 10 years across observation, stereotactic radiosurgery, and microsurgery; it also states that radiosurgery should not be considered superior to observation for hearing preservation in adults with sporadic intracanalicular or less than 2 cm vestibular schwannoma.

Clinical Implications

The article recommends considering evaluation at an academic skull base center when surgery or radiotherapy is being contemplated, particularly where multidisciplinary review and evolving surgical and radiation technologies are available. Observation may remain appropriate when recommended, and treatment planning should account for tumor control alongside cranial nerve and hearing function.

Conclusion

The source describes contemporary skull base tumor care as an individualized balance between tumor control and preservation of neurologic function. Function-preserving surgery, radiosurgery for selected residual or recurrent disease, and developing visualization technologies are presented as components of this evolving approach.